EUVIMEDEUVIMED entdecken
Crossref

Efficacy of surgical intervention in modern complex treatment for tuberculosis with multidrug-resistant and extensively drug-resistant pathogen

S. A. Kosenkov, D. A. Ivanova, M. V. Sinitsyn

Acta Biomedica Scientifica · 26.03.2026 · 11 (1) · 214-222

DOI: 10.29413/abs.2026-11.1.20 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biomedica Scientifica, online erschienen am 26.03.2026. Verfasst von S. A. Kosenkov und 2 weiteren Autor:innen. Die Arbeit nennt 18 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

One of the top priorities in phthisiology at present is the problem of tuberculosis treatment with multiple drug resistance (MDR) and extensive drug resistance (XDR) Mycobacterium tuberculosis (MBT). The unsatisfactory results of etiotropic chemotherapy associated with a large number of factors determine the need for surgical treatment. The effectiveness of surgical treatment and the advantages of using surgical techniques (in combination with chemotherapy) compared to the use of chemotherapy alone, it is currently poorly understood and undoubtedly requires research at various levels. The aim . Evaluation of the effectiveness and determination of optimal timing and risks of surgical intervention in the framework of complex treatment of tuberculosis with MDR/XDR pathogen using modern chemotherapy regimens. Materials and methods . The data on the treatment outcomes of 71 patients with MDR/XDR pathogen after surgery who received identical modern chemotherapy regimens (including bedaquiline, linezolid, fluoroquinolones, cycloserine) with a catamnesis of sufficient duration (at least 5 years) were analyzed.

Results

Successful treatment outcome (cure with transfer to the III GDN or de-registration) was registered in 83.1 % (95% CI 72.6-90.2 %). One independent risk factor for an unfavorable outcome was identified - the presence of behavioral characteristics of the patient, indicating his low adherence to treatment (p = 0.014). For relapse, the only independent risk factor was taking less than 90 doses of drugs according to the treatment regimen for drug-resistant tuberculosis, including bedaquiline and linezolid before surgery (p = 0.013).

Conclusion

The high efficiency of complex treatment during surgical intervention against the background of MDR/XDR-tuberculosis chemotherapy regimens with the inclusion of bedaquiline and linezolid has been shown. The priority role of working with patients' commitment to treatment for the prevention of adverse outcomes has been confirmed. The optimal duration of preoperative chemotherapy according to the “new” regimens (3 months or more) has been determined.

Zitieren

APA

Kosenkov, S. A., Ivanova, D. A., & Sinitsyn, M. V. (2026). Efficacy of surgical intervention in modern complex treatment for tuberculosis with multidrug-resistant and extensively drug-resistant pathogen. Acta Biomedica Scientifica, 11(1), 214-222. https://doi.org/10.29413/abs.2026-11.1.20

Vancouver

Kosenkov SA, Ivanova DA, Sinitsyn MV. Efficacy of surgical intervention in modern complex treatment for tuberculosis with multidrug-resistant and extensively drug-resistant pathogen. Acta Biomedica Scientifica. 2026;11(1):214-222. doi:10.29413/abs.2026-11.1.20

BibTeX
@article{Kosenkov2026,
  author = {Kosenkov, S. A. and Ivanova, D. A. and Sinitsyn, M. V.},
  title = {Efficacy of surgical intervention in modern complex treatment for tuberculosis with multidrug-resistant and extensively drug-resistant pathogen},
  journal = {Acta Biomedica Scientifica},
  year = {2026},
  volume = {11},
  number = {1},
  pages = {214--222},
  doi = {10.29413/abs.2026-11.1.20}
}
Kostenlos starten →